Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Avraham Karasik

Showing results (11-20 of 66) with videos related to

Pageof 7
Sort By:
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|December 7, 2019
Metabolic Control and Adherence to Therapy in Type 2 Diabetes Mellitus Patients Using IDegLira in a Real-World SettingCheli Melzer-Cohen, Gabriel Chodick, Shiran Naftelberg, et al.
The Journal of Biological Chemistry|January 10, 2002
Transactivation of ErbB2 and ErbB3 by tumor necrosis factor-alpha and anisomycin leads to impaired insulin signaling through serine/threonine phosphorylation of IRS proteinsRina Hemi, Keren Paz, Nadine Wertheim, et al.
Current Medical Research and Opinion|January 10, 2008
Sitagliptin, a DPP-4 inhibitor for the treatment of patients with type 2 diabetes: a review of recent clinical trialsAvraham Karasik, Pablo Aschner, Harvey Katzeff, et al.
Pharmacoeconomics - Open|April 27, 2021
Short-Term Excess Healthcare Costs Associated with Cardiovascular Events Among Adults with Type 2 Diabetes in Israel: A Retrospective Cohort StudyCheli Melzer Cohen, Nino Hallén, Gabriel Chodick, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|September 9, 2017
Improved Glycemic Control Achieved by Switching to Insulin Degludec in Insulin-Treated Patients with Type 2 Diabetes in a Real-World Setting: a Non-interventional, Retrospective Cohort StudyCheli Melzer Cohen, Brian Larsen Thorsted, Michael Lyng Wolden, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|March 26, 2014
Efficacy of liraglutide in a real-life cohortAnthony Heymann, Yasmin Maor, Inbal Goldstein, et al.
Artificial Intelligence in Medicine|July 9, 2022
All-cause mortality prediction in T2D patients with iTirpsPavel Novitski, Cheli Melzer Cohen, Avraham Karasik, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|April 22, 2016
Use of Healthcare Services Following Severe Hypoglycemia in Patients with Diabetes: Analysis of Real-World DataDalit Goldstein, Gabriel Chodick, Varda Shalev, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|December 20, 2005
Alendronate for osteoporosis in men with androgen-repleted hypogonadismIlan Shimon, Varda Eshed, Ram Doolman, et al.
Value in Health Regional Issues|August 18, 2020
Elevated Costs and Healthcare Resource Utilization in Patients With Type 2 Diabetes and Established Cardiovascular Disease in IsraelCheli Melzer Cohen, Nino Hallén, Gabriel Chodick, et al.
Pageof 7

Showing results (11-20 of 66) with videos related to

Sort By:
Pageof 7
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|December 7, 2019
Metabolic Control and Adherence to Therapy in Type 2 Diabetes Mellitus Patients Using IDegLira in a Real-World SettingCheli Melzer-Cohen, Gabriel Chodick, Shiran Naftelberg, et al.
The Journal of Biological Chemistry|January 10, 2002
Transactivation of ErbB2 and ErbB3 by tumor necrosis factor-alpha and anisomycin leads to impaired insulin signaling through serine/threonine phosphorylation of IRS proteinsRina Hemi, Keren Paz, Nadine Wertheim, et al.
Current Medical Research and Opinion|January 10, 2008
Sitagliptin, a DPP-4 inhibitor for the treatment of patients with type 2 diabetes: a review of recent clinical trialsAvraham Karasik, Pablo Aschner, Harvey Katzeff, et al.
Pharmacoeconomics - Open|April 27, 2021
Short-Term Excess Healthcare Costs Associated with Cardiovascular Events Among Adults with Type 2 Diabetes in Israel: A Retrospective Cohort StudyCheli Melzer Cohen, Nino Hallén, Gabriel Chodick, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|September 9, 2017
Improved Glycemic Control Achieved by Switching to Insulin Degludec in Insulin-Treated Patients with Type 2 Diabetes in a Real-World Setting: a Non-interventional, Retrospective Cohort StudyCheli Melzer Cohen, Brian Larsen Thorsted, Michael Lyng Wolden, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|March 26, 2014
Efficacy of liraglutide in a real-life cohortAnthony Heymann, Yasmin Maor, Inbal Goldstein, et al.
Artificial Intelligence in Medicine|July 9, 2022
All-cause mortality prediction in T2D patients with iTirpsPavel Novitski, Cheli Melzer Cohen, Avraham Karasik, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|April 22, 2016
Use of Healthcare Services Following Severe Hypoglycemia in Patients with Diabetes: Analysis of Real-World DataDalit Goldstein, Gabriel Chodick, Varda Shalev, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|December 20, 2005
Alendronate for osteoporosis in men with androgen-repleted hypogonadismIlan Shimon, Varda Eshed, Ram Doolman, et al.
Value in Health Regional Issues|August 18, 2020
Elevated Costs and Healthcare Resource Utilization in Patients With Type 2 Diabetes and Established Cardiovascular Disease in IsraelCheli Melzer Cohen, Nino Hallén, Gabriel Chodick, et al.
Pageof 7